Response to: 'JAK inhibitors as promising agents for refractory Takayasu arteritis' by Watanabe

被引:0
|
作者
Tanimura, Shun [1 ]
Nakamura, Hiroyuki [1 ]
Horita, Tetsuya [1 ]
机构
[1] Tomakomai City Hosp, Internal Med, Tomakomai, Hokkaido 0538567, Japan
关键词
systemic vasculitis; therapeutics; autoimmune diseases;
D O I
10.1136/annrheumdis-2020-217680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] JAK inhibitors as promising agents for refractory Takayasu arteritis
    Watanabe, Ryu
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (04)
  • [2] EXPERIENCE OF BIOLOGICAL AGENTS TREATMENT OF REFRACTORY TAKAYASU ARTERITIS IN CHILDREN
    Kostina, Y.
    Lyskina, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 527 - 527
  • [3] Biomarkers for Takayasu arteritis: Which is the most promising?
    Ishibashi, Tomohiko
    Nakaoka, Yoshikazu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 418 - 419
  • [4] Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment
    Ohigashi, Hirokazu
    Tamura, Natsuko
    Ebana, Yusuke
    Harigai, Masayoshi
    Maejima, Yasuhiro
    Ashikaga, Takashi
    Isobe, Mitsuaki
    JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 774 - 778
  • [5] Targeting JAK/STAT pathway in Takayasu's arteritis
    Regnier, Paul
    Le Joncour, Alexandre
    Maciejewski-Duval, Anna
    Desbois, Anne-Claire
    Comarmond, Cloe
    Rosenzwajg, Michelle
    Klatzmann, David
    Cacoub, Patrice
    Saadoun, David
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 951 - 959
  • [6] TARGETING JAK/STAT PATHWAY IN TAKAYASU'S ARTERITIS
    Regnier, P.
    Le Joncour, A.
    Maciejewski-Duval, A.
    Desbois, A. C.
    Comarmond, C.
    Rosenzwajg, M.
    Klatzmann, D.
    Cacoub, P.
    Saadoun, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1062 - 1062
  • [7] Efficacy of long-term treatment with TNF inhibitors in patients with refractory Takayasu arteritis
    Novikov, P.
    Smitienko, I.
    Moiseev, S.
    PRESSE MEDICALE, 2013, 42 (04): : 723 - 723
  • [8] Immune response in Takayasu arteritis
    Mirault, Tristan
    Guillet, Henri
    Messas, Emmanuel
    PRESSE MEDICALE, 2017, 46 (7-8): : E189 - E196
  • [9] Successful Treatment of Refractory Takayasu Arteritis with Tacrolimus
    Yamazaki, Hayato
    Nanki, Toshihiro
    Harigai, Masayoshi
    Miyasaka, Nobuyuki
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (07) : 1487 - 1488
  • [10] Response to: 'Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis' by Lee and Song
    Nakaoka, Yoshikazu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01)